We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-13.18%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.73B
AUM Growth
-$181M
Cap. Flow
+$81.8M
Cap. Flow %
4.72%
Top 10 Hldgs %
61.45%
Holding
403
New
38
Increased
116
Reduced
162
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 1.92%
2 Financials 1.74%
3 Industrials 1.64%
4 Energy 1.48%
5 Healthcare 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
376
Constellation Brands
STZ
$22.2B
-1,080
Closed -$233K
TCRT icon
377
Alaunos Therapeutics
TCRT
$4.59M
-181
Closed -$87K
TCOM icon
378
Trip.com Group
TCOM
$29.6B
-5,724
Closed -$213K
TT icon
379
Trane Technologies
TT
$100B
-2,002
Closed -$205K
TYG
380
Tortoise Energy Infrastructure Corp
TYG
$1.09B
-4,098
Closed -$441K
UL icon
381
Unilever
UL
$137B
-3,556
Closed -$219K
VDE icon
382
Vanguard Energy ETF
VDE
$10.1B
-6,816
Closed -$716K
XME icon
383
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
-27,308
Closed -$933K
XOP icon
384
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.65B
-1,250
Closed -$216K
ZTS icon
385
Zoetis
ZTS
$32.4B
-2,213
Closed -$203K
CNH
386
CNH Industrial
CNH
$12.7B
-12,910
Closed -$135K
NTG
387
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
-6,535
Closed -$1.05M
CGRN
388
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-4,000
Closed -$40K
SPPI
389
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-20,000
Closed -$336K
ATRS
390
DELISTED
Antares Pharma, Inc.
ATRS
-100,000
Closed -$336K
RDS.A
391
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-4,655
Closed -$317K
ETFC
392
DELISTED
E*Trade Financial Corporation
ETFC
-4,417
Closed -$231K
EQM
393
DELISTED
EQM Midstream Partners, LP
EQM
-6,308
Closed -$333K
SEMG
394
DELISTED
SEMGROUP CORPORATION
SEMG
-49,233
Closed -$1.08M
AQ
395
DELISTED
Aquantia Corp. Common Stock
AQ
-11,193
Closed -$143K
AMID
396
DELISTED
American Midstream Partners, LP
AMID
-10,000
Closed -$64K
ATHN
397
DELISTED
Athenahealth, Inc.
ATHN
-28,165
Closed -$3.76M
ESRX
398
DELISTED
Express Scripts Holding Company
ESRX
-6,980
Closed -$664K
AET
399
DELISTED
Aetna Inc
AET
-2,676
Closed -$543K
PX
400
DELISTED
Praxair Inc
PX
-1,614
Closed -$259K

Similar funds

Ballentine Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ballentine Partners held 403 positions worth $1.73B, down 9.5% from $1.92B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Ballentine Partners deployed $81.8M of net new capital in Q4 2018, opening 38 new positions and adding to 116 existing holdings. Its largest new stake was State Street SPDR Portfolio Developed World ex-US ETF: 362,130 shares worth $9.58M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 2.1% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Forrester Research, an estimated $12.6M trimmed.

  • Ballentine Partners's largest Q4 2018 buy was State Street SPDR Portfolio Developed World ex-US ETF: 362,130 shares worth $9.58M.
  • Ballentine Partners added most to iShares Core S&P Total US Stock Market ETF in Q4 2018, an estimated $17.2M increase.
  • Ballentine Partners's biggest Q4 2018 reduction was Forrester Research, cutting an estimated $12.6M.
  • Ballentine Partners fully exited Athenahealth, Inc. in Q4 2018, selling an estimated $3.76M.
  • Ballentine Partners's ten largest holdings make up 61% of its $1.73B portfolio in Q4 2018.
  • Ballentine Partners opened 38 new positions and closed 61 in Q4 2018.
  • Ballentine Partners's portfolio value fell 9.5% quarter-over-quarter to $1.73B.

Based on Ballentine Partners's 13F filing for Q4 2018, filed 4 Feb 2019.